|
Sl. No.
|
Funding Agent
|
Title of the Project
|
Amount
|
Role
|
Status
|
|
Ongoing Projects
|
|
30
|
Blockchain for Impact (BFI)-BIOM
|
Preclinical Translation of AH22: A Highly Selective and Potent Novel Epigenome-Targeting Anticancer Therapeutic/Diagnostic Molecule
|
Rs. 46 Lakhs
|
|
Just approved
|
|
29
|
Indian Council of Medical Research (ICMR), Govt. of India
|
Development of aspirin hybrids for dual targeting of cyclooxygenase and histone deacetylase as treatments for colitis-associated colorectal cancer (CAC).
|
Rs. 60,34,814
|
PI
|
Just approved
|
|
28
|
Scheme for Promotion of Academic & Research Collaboration (SPARC). Prof. Swati Biswas (PI), Prof. Adam Mechler (La Trobe, Australia) Prof. Jimmy Hsia (NTU, Singapore).
|
Formulation-based strategy to design membrane targeting antimicrobial peptide-based therapeutics for cancer and eye infections
|
Rs. 71.16 Lakhs
|
Co-PI
|
01/04/2024 (2 years)
|
|
27
|
Department of Biotechnology (DBT) under Joint DBT-NMPB, Ministry of AYUSH Call for Proposals on Biotech Interventions in Medicinal Plants
|
Molecular Studies on Bacopa monnieri to evaluate the modulation of neuronal receptors for schizophrenia using cell based and
mouse models: Submitted on January 30_2020
|
Rs. 30
Lakhs
|
Co-PI
|
01/04/2024-31/03/2027
|
|
26
|
Department of Biotechnology (DBT), Govt. of India
|
3D-Bioprinted Contact Lens Embedding Host-Defense Peptide S100A12 as Precision Medicine for Bacterial Keratitis
|
39.10 Lakhs
|
Co-PI
|
(1.5 years)
|
|
25
|
Hetero Lab Limited, R&D
Jeedimetla, Hyderabad, Telangana – 500037 India.
|
Human serum albumin –based nanoparticles as an antiproteosome therapy for the treatment of advanced metastatic triple negative breast cancer
|
Rs. 5.0 Lakhs
|
Joint PI
|
26.06.2023-2026 (3 years)
|
|
24
|
Indian Council of Medical Research (ICMR), Govt. of India
|
Revolutionizing Phototherapy with Hypoxia-Reversing Photothermal/ Photodynamic Nanoparticles-Laden In Situ Gel for Non-Invasive Tumor Ablation in Oral Cancer
|
53.13 Lakhs
|
Co-PI
|
28.02.2024-27.02.2027
|
|
23
|
Indian Council of Medical Research (ICMR), Govt. of India
|
Antibacterial Nanozyme-Laden in situ Light-Responsive Hydrogel for Tissue Regeneration and Quorum-Sensing Inhibition to Revert Antimicrobial Resistance in Diabetic Foot Ulcers
|
48.02 Lakhs
|
Co-PI
|
3 years
|
|
22
|
Scheme for Transformational and Advanced Research in Sciences (STARS) for promoting translational, India-centric research in Science; implemented and managed by IISc, Bangalore
|
Carbon dioxide-fueled Janus Motors for Targeted Delivery of Therapeutic Cargo in Helicobacter pylori Infection
|
43.15 Lakhs
|
Co-PI
|
Jan 1, 2024 (3 years)
|
|
21
|
Indian Council of Medical Research (ICMR), Govt. of India. (Proposal ID: IIRP-2023-5411)
|
Development of Self-Powered Electrochromic Smart Display for Visual Detection of Folate Receptor Overexpressed Cancer Cells
|
Rs. 41 Lakhs
|
Co-PI
|
Feb 1, 2024 (3 years)
|
|
20
|
Department of Science and Technology, Government of India (CRG-SERB) File Number: CRG/2023/003045
|
Electrochemical green synthesis of medicinally potential organo-chalcogenides and chalcogenoxides and evaluation of their anti-cancer activities in search of novel anti-cancer agents
|
Rs. 43.486Lakhs
|
Co-PI
|
Jan 19, 2024 (3 years)
|
|
19
|
Indian Council of Medical Research (ICMR), Govt. of India
|
Development of epigenetic modulators as therapeutics for cognitive deficit associated with psychosis using novel selective histone deacetylase-3 inhibitors
|
34.84
Lakhs
|
PI
|
Ongoing 25.03.2023
– 24.03.2026
|
|
18
|
Indian Council of Medical Research (ICMR), Govt. of India
|
HDAC3 and its functional role in the progression of cognitive deficits as a secondary complication to chronic kidney disease (CKD).
|
31.16
Lakhs
|
Co-PI
|
Ongoing; 01.03.2023
- 28.02.2026
|
|
17
|
Indian Council of Medical Research (ICMR), Govt. of India
|
Tailor-made, Tumor-Targeted Vitaprotein Nanoparticles of Lapatinib and Letrozole as NanoChemo-Cocktail. for Hormone- Receptor-Amplified Advanced Metastatic Breast Cancers Treatment.
|
28.82
Lakhs
|
Co-PI
|
Ongoing; 27.01.2023
– 26.01.20226
(3 Yrs)
|
|
16
|
Indian Council of Medical Research (ICMR), Govt. of India
|
Design and development of portable acidosis kit for the rapid, trace-level
detection of Ketone bodies in biological samples
|
34.366
Lakhs
|
Co-PI
|
Ongoing; 01.04.2023–
31.03.2026
(3 Yrs)
|
|
15
|
DBT-BUILDER (Boost to University Interdisciplinary Life Science Departments for Education and Research).
Government of India
|
Interdisciplinary Life Science Programme for Advanced Research and Education
|
300
Lakhs
|
PI
|
22.7.2021 -21.7.2026 (5yr)
|
|
Completed Projects
|
|
14
|
Department of Health Research (DHR-ICMR). Government of India
|
Development of Epigenome Targeted Therapeutics with Improved Selectivity and Drug-ability for the Treatment of Cancer
|
30.483
Lakhs
|
PI
|
Complete 15.12.2021
to14.5.2025
|
|
13
|
Council of Scientific and Industrial Research (CSIR), Government of India
|
Development of Cost-effective, Electrophilic Trifluoromethylating Reagents and Their Application to the Syntheses of New Classes of Medicinally Potential Trifluoromethylated Heterocycles
|
25 Lakhs
(Received 1255830)
|
Co-PI
|
Complete (01.04.2021
-31.03.2024
(3 Yrs)
|
|
12
|
BITS-Pilani Hyderabad Campus
|
Validation of therapeutic activity in preclinical models
|
20 Lakhs
|
PI
|
Jan 2023 to Dec 2023
|
|
11
|
Council of Scientific and Industrial Research (CSIR) Government of India
|
Bifunctional Gene-Expression Modulating Chemotherapeutic Agents as Improved Treatment Strategy for Cancer
|
26.06
Lakhs
|
PI
|
01.06.201931.05.2022
|
|
10
|
Department of Science and Technology, Government of India (SERB-DST)
|
Near-Infrared Light Degradable Nanomicellar Chemo-Photodynamic Therapy using Aerobic Chlorin e6 Conjugate for Oropharyngeal Carcinomas
|
30.72
|
Co-PI
|
Complete 29.04.2019-28.04.2022;
3 yrs.
|
|
9
|
Indian Council of Medical Research (ICMR), Govt. of India
|
Functional role of histone deacetylase 6 (HDAC6) in the progression of oral squamous cell carcinoma: regulation of IL-1 beta expression, autophagy and epithelial- mesenchymal transition (EMT)
|
26 Lakhs
|
Co-PI
|
Complete
(09.09.2019 -
8.9.2022)
|
|
8
|
Dr. Reddy’s Laboratory (DRL), Hyderabad
|
Formulation development and physico-chemical/in vitro/in vivo characterization of a nano-suspension formulation of an anticancer drug.
|
8.01
Lakhs
|
PI
|
Complete (2018-2022)
|
|
7
|
Department of Science and Technology, Government of India (SERB-DST)
|
Design, Synthesis and Biological Evaluation of HDAC3 Selective Inhibitors as Long-Term Memory Enhancers
|
29.87
Lakhs
|
PI
|
Complete 28.08.2017-
27.08.2021
|
|
6
|
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (SPARC), India
|
Chemically modified epigenome targeted anticancer drug development
|
29 Lakhs
|
PI
|
Completed (2016-2018)
|
|
5
|
Daewoong Pharmaceuticals, Seoul, Republic of Korea
|
Development for sustained release injectable formulations
|
22 Lakhs
|
PI
|
Complete 18.07.2015-17.07.2017
|
|
4
|
Department of Biotechnology (DBT), Government of India
|
Cell penetrating peptide octa- arginine anchored, multifunctional poly(amidoamine) dendrimer to promote delivery of chemotherapeutics in cancer
|
37 Lakhs
|
Co-PI
|
Complete 21.04.2015- 20.05.2028
|
|
3
|
Additional Competitive Research Grant: Birla Institute of Technology and Science- Pilani
|
Design and Development of Isoform Selective HDAC3 Inhibitors for the Enhancement of Long-term Memory
|
9 Lakhs
|
PI
|
Completed (2015-2017)
|
|
2
|
Department of Science and Technology (DST), Government of India (Indo-Belarus).
|
Tumor targeted nanomedicines for photodynamic therapy
|
9.58 Lakhs
|
Co-PI
|
Complete 30.03.2015-31.03.2017
|
|
1
|
Research Initiation Grant: Birla Institute of Technology and Science-Pilani at Hyderabad
Campus
|
Development of Cognitive Enhancers that Inhibit Histone Deacetylase Activity and Modulate Chromatin-mediated Neuroplasticity
|
2 Lakhs
|
PI
|
Complete 31.10.2013-30.10.2015
|
